| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CI | Common Stock, $.01 Par Value | Award | $0 | +1.17K | +17.86% | $0.00 | 7.75K | Feb 24, 2023 | Direct | F1 |
| transaction | CI | Common Stock, $.01 Par Value | Tax liability | -$20.9K | -71 | -0.92% | $294.27 | 7.68K | Feb 24, 2023 | Direct | F2 |
| transaction | CI | Common Stock, $.01 Par Value | Tax liability | -$109K | -371 | -4.83% | $294.27 | 7.31K | Feb 24, 2023 | Direct | F3 |
| transaction | CI | Common Stock, $.01 Par Value | Sale | -$236K | -803 | -10.99% | $294.06 | 6.5K | Feb 27, 2023 | Direct | F4 |
| holding | CI | Common Stock, $.01 Par Value | 1.7K | Feb 24, 2023 | By 401(k) | F5 |
| Id | Content |
|---|---|
| F1 | The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2020-2022 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. |
| F2 | Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. |
| F3 | Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. |
| F4 | This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2022. |
| F5 | Represents shares acquired through ongoing participation in Cigna's 401(k) Plan. |